Kushner: Agreement on economic pathway vital for Middle East peace

MANAMA (Reuters) - Senior White House adviser Jared Kushner said on Tuesday that prosperity for the Palestinians was not possible without a fair political solution - but that agreement on an economic way forward was a necessary precondition for Israeli-Palestinian peace.

Reuters June 26, 2019 00:06:58 IST
Kushner: Agreement on economic pathway vital for Middle East peace

Kushner Agreement on economic pathway vital for Middle East peace

MANAMA (Reuters) - Senior White House adviser Jared Kushner said on Tuesday that prosperity for the Palestinians was not possible without a fair political solution - but that agreement on an economic way forward was a necessary precondition for Israeli-Palestinian peace.

Kushner was addressing the opening of a workshop in Bahrain to showcase the economic portion of Washington's long-awaited Arab-Israeli peace plan, a $50 billion development blueprint unveiled this week that has been sharply criticised by Palestinians and Arabs across the region.

"What we have developed is the most comprehensive economic plan ever created specifically for the Palestinians and the broader Middle East," he told an audience that included International Monetary Fund Managing Director Christine Lagarde.

"We can turn this region from a victim of past conflicts into a model for commerce and advancement throughout the world."

The lack of a political solution, which Washington has said will be unveiled later, has prompted rejection not only from Palestinians but in Arab countries with which Israel seeks to normalise relations. Neither the Israeli nor Palestinian governments were attending the curtain-raising event in Manama.

"My direct message to the Palestinian people is that, despite what those who have let you down in the past say, President Trump and America have not given up on you. This workshop is for you," Kushner said.

He said economic growth and prosperity for the Palestinians were not possible without an "enduring and fair political solution" to the conflict - one that guaranteed Israel’s security and respected the dignity of the Palestinian people.

"However, today is not about the political issues. We will get to those at the right time," he said.

(Reporting by Matt Spetalnick in Manama, Aziz El Yaakoubi and Nafisa Eltahir in Dubai; Writing by Ghaida Ghantous; Editing by Catherine Evans)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.

AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness
Business

AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness

By Michael Holden LONDON (Reuters) - AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday. The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout